Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tanabe Consulting Co.,Ltd. (9644.T)
Osaka, JP
Tanabe Consulting Co.,Ltd. functions as a specialized management and marketing consultancy, providing a wide array of services to its clientele. These offerings include strategic guidance for sales and digital promotion, advisory on mergers and acquisitions, human resource development programs, and various forms of expert consultation spanning functional areas, specific domains, and general business management, in addition to conducting strategy research and offering overall business management solutions. The firm serves a diverse range of industries, including healthcare, infrastructure, manufacturing, tourism, agriculture, education, and more. Founded in 1957 and headquartered in Osaka, Japan, Tanabe Consulting operates an extensive office network across 10 cities throughout the country. It was formerly recognized as Tanabe Management Consulting Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.97% | +0.41% | +1.82% | -0.27% | +4.30% | -2.67% | -1.49% | +63.96% | +111.32% | +169.63% | +810.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Consulting Services: +8.7%+12.0% ★ Q1'26: +15.2% (vs Q1'25)
-
EPS growth Consulting Services: +10.0%+10.1% ★ Q1'26: +39.1% (vs Q1'25)
-
FCF margin FCF growth · Consulting Services: +16.4%+8.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Consulting Services: +14.1%+11.1% Q1'26: +5.0% (vs Q1'25)
-
ROIC Consulting Services: +12.0%+25.4% ★ Q1'26: +15.6% (vs Q1'25)
-
Share dilution Consulting Services: +0.6%-1.7% ★ Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Consulting Services: -0.79×0.32× ★ Q1'26: 0.59× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
7.87B
est: 7.90B (-0.4%)
|
8.30B
est: 8.20B (+1.2%)
|
9.21B
est: 9.50B (-3.0%)
|
10.57B
est: 9.85B (+7.3%)
|
11.76B
est: 11.95B (-1.6%)
|
12.74B
est: 12.78B (-0.3%)
|
14.54B
est: 13.87B (+4.9%)
|
15.06B
15.06B – 15.06B
+8.6% YoY
|
| EBITDA |
842.20M
est: 848.69M (-0.8%)
|
929.24M
est: 880.92M (+5.5%)
|
867.48M
est: 1.02B (-15.0%)
|
1.07B
est: 1.06B (+0.7%)
|
1.30B
est: 1.28B (+1.4%)
|
1.19B
est: 1.77B (-32.8%)
|
1.72B
est: 1.92B (-10.4%)
|
2.09B
2.09B – 2.09B
+8.6% YoY
|
| EBIT |
762.70M
est: 741.83M (+2.8%)
|
856.17M
est: 770.00M (+11.2%)
|
751.65M
est: 892.07M (-15.7%)
|
926.32M
est: 924.94M (+0.1%)
|
1.16B
est: 1.12B (+3.0%)
|
1.01B
est: 1.54B (-34.3%)
|
1.50B
est: 1.67B (-10.0%)
|
1.81B
1.81B – 1.81B
+8.6% YoY
|
| Net Income |
315.63M
|
582.40M
|
498.47M
est: 518.15M (-3.8%)
|
604.31M
est: 700.79M (-13.8%)
|
724.47M
est: 722.28M (+0.3%)
|
641.03M
est: 821.44M (-22.0%)
|
1.02B
est: 1.02B (-0.1%)
|
1.18B
1.18B – 1.18B
+16.2% YoY
|
| SGA |
2.71B
est: 2.80B (-3.2%)
|
2.87B
est: 2.91B (-1.4%)
|
3.36B
est: 3.37B (-0.4%)
|
3.86B
est: 3.49B (+10.5%)
|
4.05B
est: 4.24B (-4.4%)
|
4.46B
est: 4.54B (-1.8%)
|
5.11B
est: 4.92B (+3.8%)
|
5.35B
5.35B – 5.35B
+8.6% YoY
|
| EPS |
9.11
|
16.81
|
14.47
est: 15.68 (-7.7%)
|
17.53
est: 21.20 (-17.3%)
|
21.13
est: 21.85 (-3.3%)
|
19.07
est: 24.85 (-23.3%)
|
30.81
est: 30.80 (+0.0%)
|
35.80
35.80 – 35.80
+16.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Itaru Okumura | Senior MD & Director | — | male |
| Masaru Warata | Senior MD & Director | — | male |
| Norihito Minamikawa | Senior MD & Director | — | male |
| Takahiko Wakamatsu | Chairman, President, Compliance Officer & Chief Executive Officer | — | male |
| Yoshikuni Nagao | Executive Vice President & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9644.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
